Cypress Capital Group reduced its holdings in CME Group Inc. (NASDAQ:CME) by 1.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 63,462 shares of the financial services provider’s stock after selling 1,234 shares during the period. CME Group makes up 1.8% of Cypress Capital Group’s portfolio, making the stock its 12th largest holding. Cypress Capital Group’s holdings in CME Group were worth $7,947,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CME. RMB Capital Management LLC lifted its holdings in shares of CME Group by 3.1% in the 1st quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after acquiring an additional 3,501 shares during the last quarter. Capital Advisors Inc. OK lifted its holdings in shares of CME Group by 10.7% in the 2nd quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after acquiring an additional 8,198 shares during the last quarter. Marvin & Palmer Associates Inc. lifted its holdings in shares of CME Group by 100.7% in the 2nd quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after acquiring an additional 28,745 shares during the last quarter. Captrust Financial Advisors bought a new stake in shares of CME Group in the 2nd quarter worth about $693,000. Finally, Thrivent Financial For Lutherans lifted its holdings in shares of CME Group by 5.6% in the 1st quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock worth $1,485,000 after acquiring an additional 660 shares during the last quarter. 82.64% of the stock is owned by institutional investors and hedge funds.

CME Group Inc. (NASDAQ:CME) traded down 0.12% during midday trading on Wednesday, hitting $137.06. 179,987 shares of the stock traded hands. The company’s 50-day moving average is $131.34 and its 200 day moving average is $123.53. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $138.49. The firm has a market cap of $46.59 billion, a P/E ratio of 33.76 and a beta of 0.73.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The business had revenue of $925.00 million for the quarter, compared to analysts’ expectations of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.14 earnings per share. On average, analysts anticipate that CME Group Inc. will post $4.82 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Monday, September 25th. Investors of record on Friday, September 8th were issued a $0.66 dividend. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 1.92%. CME Group’s dividend payout ratio (DPR) is 53.99%.

TRADEMARK VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.thecerbatgem.com/2017/10/11/cypress-capital-group-sells-1234-shares-of-cme-group-inc-cme.html.

Several equities research analysts have recently issued reports on CME shares. Wells Fargo & Company raised their target price on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. Jefferies Group LLC restated a “buy” rating and issued a $134.00 target price (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. Barclays PLC started coverage on shares of CME Group in a report on Friday, September 8th. They issued an “overweight” rating and a $139.00 target price for the company. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, September 13th. Finally, Keefe, Bruyette & Woods restated a “hold” rating and issued a $133.00 target price on shares of CME Group in a report on Thursday, September 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $135.89.

In related news, Chairman Terrence A. Duffy sold 21,815 shares of the firm’s stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total value of $2,702,660.35. Following the sale, the chairman now owns 110,711 shares of the company’s stock, valued at $13,715,985.79. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 300 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $124.78, for a total transaction of $37,434.00. Following the completion of the sale, the director now directly owns 4,009 shares in the company, valued at approximately $500,243.02. The disclosure for this sale can be found here. In the last ninety days, insiders sold 47,094 shares of company stock worth $5,896,940. 0.57% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.